Endogenous production of nitric oxide synthase inhibitors
Asymmetric dimethylarginine (ADMA) and cardiovascular disease
ADMA and hyperhomocysteinemia
Insulin resistance
DDAH gene and cardiovascular risk
Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA)
Spotlight on endothelial progenitor cell inhibitors
Asymmetric dimethylarginine (ADMA) accelerates cell senescence
ADMA metabolism and clearance
Arginine metabolism in vascular biology and disease
Quantification of ADMA
ADMA and oxidative stress may relate to the progression of renal disease
Calender of events